SCHEMBL7593965

SCHEMBL7593965

O=C1C=CC=CC1N[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4627320 0.63 NFKB1 (0.44)
SCHEMBL27648274 0.57
SCHEMBL2222566 0.57
SCHEMBL28166935 0.57
SCHEMBL10455846 0.57
SCHEMBL8144801 0.57
SCHEMBL934476 0.57
SCHEMBL38655889 0.57
SCHEMBL21650075 0.51 RAB9A (0.33)
SCHEMBL1476442 0.49 MEN1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3047008-A1 LAUNDRY CARE COMPOSITION COMPRISING CARBOXYLATE DYE The Procter & Gamble Company (US) 2016-07-27 EP disclosed
EP-3046971-A2 LAUNDRY CARE COMPOSITION COMPRISING CARBOXYLATE DYE Milliken & Company (US) 2016-07-27 EP disclosed
WO-2015041887-A2 LAUNDRY CARE COMPOSITION COMPRISING CARBOXYLATE DYE MILLIKEN & COMPANY (US) 2015-03-26 WO disclosed
WO-2015042086-A1 LAUNDRY CARE COMPOSITION COMPRISING CARBOXYLATE DYE THE PROCTER & GAMBLE COMPANY (US) 2015-03-26 WO disclosed
US-6455698-B1 FOR TREATING CEREBRAL ISCHEMIA OR CEREBRAL INFARCTION RESULTING FROM THROMBOEMBOLIC OR HEMORRHAGIC STROKE, CEREBRAL VASOSPASMS, HYPOGLYCEMIA, CARDIAC ARREST, NEURODEGENERATIVE DISORDERS WARNER-LAMBERT COMPANY 2002-09-24 US disclosed
US-20020065415-A1 Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents KORNBERG BRIAN EDWARD (US) 2002-05-30 US disclosed
US-6340758-B1 DRUGS AS NEUROPROTECTIVE AGENTS INVENTION MAY ALSO BE USEFUL IN THE TREATMENT OF SCHIZOPHRENIA, EPILEPSY, ANXIETY, PAIN AND DRUG ADDICTION. WARNER-LAMBERT COMPANY 2002-01-22 US disclosed